blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2061451

EP2061451 - BIS(THIOHYDRAZIDE AMIDES) FOR TREATING MELANOMA [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  11.02.2011
Database last updated on 20.12.2024
Most recent event   Tooltip11.02.2011Application deemed to be withdrawnpublished on 16.03.2011  [2011/11]
Applicant(s)For all designated states
Synta Pharmaceuticals Corporation
45 Hartwell Avenue
Lexington, MA 02421 / US
[2009/22]
Inventor(s)01 / MCLEOD, Matthew
371 Shawmut Avenue
Boston, MA 02118 / US
 [2009/22]
Representative(s)Snodin, Michael D.
Potter Clarkson LLP The Belgrave Centre
Talbot Street
Nottingham NG1 5GG / GB
[N/P]
Former [2009/22]Snodin, Michael D.
Potter Clarkson LLP Park View House 58 The Ropewalk Nottingham
NG1 5DD / GB
Application number, filing date07837061.620.08.2007
[2009/22]
WO2007US18381
Priority number, dateUS20060838977P21.08.2006         Original published format: US 838977 P
[2009/22]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2008024305
Date:28.02.2008
Language:EN
[2008/09]
Type: A2 Application without search report 
No.:EP2061451
Date:27.05.2009
Language:EN
The application published by WIPO in one of the EPO official languages on 28.02.2008 takes the place of the publication of the European patent application.
[2009/22]
Search report(s)International search report - published on:EP19.06.2008
ClassificationIPC:A61K31/16, A61K31/165, A61K31/337, A61K45/06, A61P35/00, A61P17/00
[2009/22]
CPC:
A61K31/16 (EP,US); A61K31/165 (EP,US); A61K31/337 (EP,US);
A61K45/06 (EP,US); A61P17/00 (EP); A61P35/00 (EP);
A61P37/04 (EP) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2009/22]
Extension statesAL20.03.2009
BA20.03.2009
HR20.03.2009
MK20.03.2009
RS20.03.2009
TitleGerman:BIS(THIOHYDRAZIDAMIDE) FÜR MELANOMBEHANDLUNG[2009/22]
English:BIS(THIOHYDRAZIDE AMIDES) FOR TREATING MELANOMA[2009/22]
French:TRAITEMENT DU MÉLANOME PAR DES BIS(THIO-HYDRAZIDE AMIDES)[2009/22]
Entry into regional phase20.03.2009National basic fee paid 
20.03.2009Designation fee(s) paid 
20.03.2009Examination fee paid 
Examination procedure20.03.2009Examination requested  [2009/22]
01.05.2009Amendment by applicant (claims and/or description)
25.02.2010Despatch of a communication from the examining division (Time limit: M06)
08.09.2010Application deemed to be withdrawn, date of legal effect  [2011/11]
14.10.2010Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2011/11]
Fees paidRenewal fee
24.08.2009Renewal fee patent year 03
25.08.2010Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[E]WO2008024301  (SYNTA PHARMACEUTICAL CORP [US], et al) [E] 1-191 * abstract * * page 1, line 24 - page 2, line 21 * * page 3, line 1 - page 5, line 22 * * page 12, line 3 - page 15, line 4 * * page 32, line 1 - page 47, line 5 * * page 55, line 24 - page 57, line 18; example -; claim - *;
 [PX]WO2006113695  (SYNTA PHARMACEUTICALS CORP [US], et al) [PX] 1-29,34-40,43,46-75,80-86,89,92-121,126-131,135,138-167,172-178,181,184 * abstract * * page 4, line 10 - page 5, line 10 * * page 6, line 21 - line 26 * * page 34, line 15 - line 28; example 4 * * claim - *;
 [PX]EP1731148  (SYNTA PHARMACEUTICALS CORP [US]) [PX] 1-29,34-40,43,46-75,80-86,89,92-121,126-131,135,138-167,172-178,181,184 * abstract * * page 10, paragraph 60; claim - *;
 [X]WO2004064826  (SYNTA PHARMACEUTICALS CORP [US], et al) [X] 1-191 * abstract * * page 19, line 14 - line 28 * * page 22, line 15 - page 31, line 15; example 15 * * figure -; claim - *;
 [X]WO2006055747  (SYNTA PHARMACEUTICALS CORP [US], et al) [X] 1-29,34-40,43,46-75,80-86,89,92-121,126-131,135,138-167,172-178,181,184 * page 14, line 12 - line 15; example 13 *;
 [X]WO03006428  (SBR PHARMACEUTICALS CORP [US], et al) [X] 1-29,34-40,43,46-75,80-86,89,92-121,126-131,135,138-167,172-178,181,184 * abstract * * page 16, paragraph L - page 17, line 7; example -; claim - *;
 [X]WO03006430  (SBR PHARMACEUTICALS CORP [US], et al) [X] 1-29,34-40,43,46-75,80-86,89,92-121,126-131,135,138-167,172-178,181,184 * abstract * * page 15, line 16 - line 24; example -; claim - *
 [X]  - GEHRMANN MATHIAS, "Drug evaluation: STA-4783 - enhancing taxane efficacy by induction of Hsp70", CURRENT OPINION IN INVESTIGATIONAL DRUGS, PHARMAPRESS, US, (200606), vol. 7, no. 6, ISSN 1472-4472, pages 574 - 580, XP008087326 [X] 1-29,34-40,43,46-75,80-86,89,92-121,126-131,135,138-167,172-178,181,184 * the whole document *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.